Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GLP1R | P43220 | 8/20 | 0.52 |
| ▸ | NMT1 | P30419 | 5/20 | 0.41 |
| ▸ | NMT2 | O60551 | 4/20 | 0.41 |
| ▸ | FOLH1 | Q04609 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL27410394 | 0.95 | GLP1R (0.58) | GLP1RNMT1NMT2 | |
| SCHEMBL2374399 | 0.94 | GLP1R (0.59) | GLP1RNMT1NMT2 | |
| SCHEMBL18552085 | 0.86 | GLP1R (0.57) | GLP1RFOLH1 | |
| SCHEMBL27411240 | 0.86 | GLP1R (0.57) | GLP1RFOLH1 | |
| SCHEMBL27407839 | 0.86 | GLP1R (0.57) | GLP1RFOLH1 | |
| SCHEMBL24899341 | 0.86 | GLP1R (0.57) | GLP1RFOLH1 | |
| SCHEMBL24390490 | 0.86 | GLP1R (0.57) | GLP1RFOLH1 | |
| SCHEMBL2177917 | 0.86 | GLP1R (0.57) | GLP1RFOLH1 | |
| SCHEMBL27409367 | 0.86 | GLP1R (0.57) | GLP1RFOLH1 | |
| SCHEMBL18560335 | 0.86 | GLP1R (0.57) | GLP1RFOLH1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20240209028-A1 | CNP COMPOUNDS | NOVO NORDISK A/S (DK) | 2024-06-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240209028-A1 | CNP COMPOUNDS | NPPA, NPR1, NPR3 | GLP1R 19/4885NMT1 947/4885NMT2 656/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.